News
Lawreen Connors, Ph.D., has been promoted to Professor of Pathology and Laboratory Medicine
The Department of Pathology and Laboratory Medicine is very pleased to announce that Lawreen Connors, Ph.D., has been promoted to Professor of Pathology and Laboratory Medicine. Dr. Connors obtained her Ph.D. in biochemistry from Boston University and has risen through the academic ranks through her appointments in Biochemistry and Pathology. She publishes extensively in the […]
Well-received oral presentation of Dr. Avital Angel-Korman and her mentor Dr. Andrea Havasi at American Society of Nephrology in San Diego
We are pleased and proud to announce a well-received oral presentation of Dr. Avital Angel-Korman and her mentor Dr. Andrea Havasi at American Society of Nephrology in San Diego on October 26, 2018 on “Long term outcomes of renal transplantation in AL amyloidosis”. Congratulations to Dr. Angel-Korman and Dr. Havasi.
Dr. Gareth Morgan joins our dynamic team of researchers as a Research Assistant Professor
We are ecstatic to introduce Dr. Gareth Morgan as he becomes a member of the BU Amyloidosis Center. Dr. Morgan joins our dynamic team of researchers as a Research Assistant Professor from today. We extend our warm welcome to Dr. Morgan and wish him the best in continuing basic and translational research in AL amyloidosis. […]
Hematologist on our multidisciplinary clinical team, Dr. Mark Sloan, @jmarksloan, was named as an Evans Outstanding Clinician
We are proud to announce that the hematologist on our multidisciplinary clinical team, Dr. Mark Sloan, @jmarksloan, was named as an Evans Outstanding Clinician. He is being recognized as for clinical skills, attributes and professionalism that define excellence. This award is intended to acknowledge the value of clinical medicine and honor clinical role models among the […]
2019 House and Senate language on Amyloidosis
August 24, 2018 Last night the Senate passed the fiscal year 2019 Labor HHS bill. This is the first time the bill has passed the Senate floor in a decade. This gives more emphasis to language included in the Senate and House reports on Amyloidosis and the hope for completing a House Senate conference and […]
FDA COULD MAKE A HISTORIC DECISION FOR AMYLOIDOSIS PATIENTS
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
Repurposing a cardiac test to help diagnose cardiac transthyretin amyloidosis
Featuring Dr. Frederick L. Ruberg, our senior cardiologist | Read more below https://www.cardiovascularbusiness.com/topics/imaging/resurrecting-tc-99m-pyp-cardiac-amyloidosis-therapies-emerge-old-test-gains-new
Proud to Present Dr. John Berk’s Research in hereditary ATTR Amyloidosis in New England Journal of Medicine
We are proud to announce 2 publications in the New England Journal of Medicine highlighting Dr. John Berk’s research in hereditary ATTR amyloidosis. You can find both articles linked below. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis NEJM | PubMed Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis NEJM | PubMed Congratulations to Dr. […]
3rd Annual Fit To Be Tied Race Wrap-Up
We would like to give a big shout-out to everyone that came out to the 3rd Annual Fit to Be Tied in support for Amyloidosis, which took place on May 20th, 2018 in Onondaga Lake Park in Liverpool, NY. We would also like to sincerely thank Ms. Floris Palmer and everyone who makes Fit to […]
Dr. Alan S. Cohen, founding Director of the Amyloidosis Center, passes away at age 92
It is with the utmost sorrow that we announce the passing of Dr. Alan S. Cohen, the founding director of The Amyloidosis Center. Dr. Cohen established The Amyloidosis Center as well as the first Arthritis section at the Boston University School of Medicine in 1960. His contributions in the clinical and scientific study of Amyloidosis […]